Protective actions of sex steroid hormones in Alzheimer’s disease

[1]  C. Pike,et al.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease , 2011, Neurobiology of Aging.

[2]  P. Zandi,et al.  Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women , 2011 .

[3]  F. Sohrabji,et al.  Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats , 2010, Neurobiology of Aging.

[4]  Thomas C. Foster,et al.  Estrogen effects on cognition and hippocampal transcription in middle-aged mice , 2009, Neurobiology of Aging.

[5]  B. Yankner,et al.  Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[6]  C. Pike,et al.  Progesterone Attenuates Oestrogen Neuroprotection Via Downregulation of Oestrogen Receptor Expression in Cultured Neurones , 2009, Journal of neuroendocrinology.

[7]  Jian Huang,et al.  Estrogen Regulation of the Neprilysin Gene Through A Hormone-Responsive Element , 2009, Journal of Molecular Neuroscience.

[8]  M. Schumacher,et al.  Progesterone and progestins: neuroprotection and myelin repair. , 2008, Current opinion in pharmacology.

[9]  C. Pike,et al.  Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats , 2008, Neuroscience Letters.

[10]  P. Hoyer,et al.  Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouse , 2008, Neurobiology of Aging.

[11]  H. G. Park,et al.  Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. , 2008, Journal of neurotrauma.

[12]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[13]  Ohad Parnes,et al.  Inflammation , 2008, The Lancet.

[14]  D. Brann,et al.  Role of Dickkopf-1, an Antagonist of the Wnt/β-Catenin Signaling Pathway, in Estrogen-Induced Neuroprotection and Attenuation of Tau Phosphorylation , 2008, The Journal of Neuroscience.

[15]  J. Bohacek,et al.  Long‐Term Ovarian Hormone Deprivation Alters the Ability of Subsequent Oestradiol Replacement to Regulate Choline Acetyltransferase Protein Levels in the Hippocampus and Prefrontal Cortex of Middle‐Aged Rats , 2008, Journal of neuroendocrinology.

[16]  F. Sohrabji,et al.  Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases. , 2008, Endocrinology.

[17]  J. Manson,et al.  P4-402: Baseline cognitive and demographic characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) , 2008, Alzheimer's & Dementia.

[18]  Paul S. Aisen,et al.  Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model , 2008, Brain Research.

[19]  M. Sastre,et al.  Interactions between APP secretases and inflammatory mediators , 2008, Journal of Neuroinflammation.

[20]  C. Pike,et al.  Androgens regulate neprilysin expression: role in reducing β‐amyloid levels , 2008, Journal of neurochemistry.

[21]  E. Cadenas,et al.  Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. , 2008, Endocrinology.

[22]  Domenico Lio,et al.  Inflammation, genes and zinc in Alzheimer's disease , 2008, Brain Research Reviews.

[23]  K. Koike,et al.  Ovariectomy increases neuronal amyloid-β binding alcohol dehydrogenase level in the mouse hippocampus , 2008, Neurochemistry International.

[24]  Jacob Raber,et al.  AR, apoE, and cognitive function , 2008, Hormones and Behavior.

[25]  C. Pike,et al.  Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. , 2008, Endocrinology.

[26]  Richard F. Thompson,et al.  Progesterone receptors: Form and function in brain , 2008, Frontiers in Neuroendocrinology.

[27]  Benjamin Tycko,et al.  Estrogen Receptor-α Variants Increase Risk of Alzheimer’s Disease in Women with Down Syndrome , 2008, Dementia and Geriatric Cognitive Disorders.

[28]  C. Pike,et al.  Androgen regulation of β-amyloid protein and the risk of Alzheimer's disease , 2008, Brain Research Reviews.

[29]  T. Tsurugizawa,et al.  Rapid modulation of synaptic plasticity by estrogens as well as endocrine disrupters in hippocampal neurons , 2008, Brain Research Reviews.

[30]  Xin-an Liu,et al.  Estradiol Attenuates Tau Hyperphosphorylation Induced by Upregulation of Protein Kinase-A , 2008, Neurochemical Research.

[31]  A. Walf,et al.  Effects of progesterone administration and APPswe+PSEN1Δe9 mutation for cognitive performance of mid-aged mice , 2008, Neurobiology of Learning and Memory.

[32]  D. Bennett,et al.  Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. , 2008, Current Alzheimer research.

[33]  D. Grobbee,et al.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. , 2008, JAMA.

[34]  Christian J Pike,et al.  Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease. , 2008, Brain research reviews.

[35]  R. Martins,et al.  Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels. , 2008, Journal of Alzheimer's disease : JAD.

[36]  Frank Z. Stanczyk,et al.  Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[37]  F. Goldstein,et al.  Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. , 2007, Journal of andrology.

[38]  A. Zlotta,et al.  Prostate cancer prevention , 2007, Cancer.

[39]  S. Resnick,et al.  Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. , 2007, The Journal of clinical endocrinology and metabolism.

[40]  R. Anwyl,et al.  Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. , 2007, Biochemical Society transactions.

[41]  Roberta Diaz Brinton,et al.  Estrogen receptor α and β differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons , 2007, Brain Research.

[42]  L. Freedman,et al.  Selective androgen receptor modulators for frailty and osteoporosis. , 2007, Current opinion in investigational drugs.

[43]  D. Melchiorri,et al.  Nanomolar concentrations of anabolic–androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures , 2007, Brain Research.

[44]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[45]  L. Hamann,et al.  Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators. , 2007, Bioorganic & medicinal chemistry letters.

[46]  R. Brinton,et al.  Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons. , 2007, Journal of medicinal chemistry.

[47]  Haixia Wang,et al.  Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications. , 2007, Journal of medicinal chemistry.

[48]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[49]  Thuy-vi Nguyen,et al.  Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection. , 2007, Endocrinology.

[50]  L. K. Marriott,et al.  Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane. , 2007, Minerva endocrinologica.

[51]  Meharvan Singh,et al.  Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. , 2007, Endocrinology.

[52]  D. Brann,et al.  Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications , 2007, Steroids.

[53]  R. Struble,et al.  Estradiol regulation of astroglia and apolipoprotein E: An important role in neuronal regeneration , 2007, Experimental Gerontology.

[54]  M. Yao,et al.  Estrogen Regulates Bcl-w and Bim Expression: Role in Protection against β-Amyloid Peptide-Induced Neuronal Death , 2007, The Journal of Neuroscience.

[55]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[56]  A. Ferreira,et al.  Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons , 2007, Neuroscience.

[57]  C. Cotman,et al.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease , 1995, Molecular Neurobiology.

[58]  Stanley R Krystek,et al.  Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. , 2007, Endocrinology.

[59]  Son Thanh Nguyen,et al.  Sex steroids modulate α1‐adrenoceptor‐stimulated Ca2+ elevation in human cultured prostatic stromal cells , 2007, The Prostate.

[60]  E. Wilson.  Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator. , 2007, Endocrinology.

[61]  Meharvan Singh.  Ovarian hormones elicit phosphorylation of akt and extracellular-signal regulated kinase in explants of the cerebral cortex , 2007, Endocrine.

[62]  Roberta Diaz Brinton,et al.  Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. , 2007, Brain research.

[63]  Frank M LaFerla,et al.  Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease , 2006, The Journal of Neuroscience.

[64]  Huaxi Xu,et al.  Estrogen, β‐Amyloid Metabolism/Trafficking, and Alzheimer's Disease , 2006, Annals of the New York Academy of Sciences.

[65]  P. Riederer,et al.  From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain , 2006, Journal of Neural Transmission.

[66]  Matthew T. Haren,et al.  Andropause: a quality-of-life issue in older males. , 2006, The Medical clinics of North America.

[67]  C. Pike,et al.  Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus , 2006, Brain Research.

[68]  K. Francis,et al.  Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle‐aged ovariectomized female rats , 2006, The European journal of neuroscience.

[69]  S. Chongthammakun,et al.  17beta-estradiol is protective in spinal cord injury in post- and pre-menopausal rats. , 2006, Journal of neurotrauma.

[70]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[71]  F. Sohrabji,et al.  Temporal expression of IL-1β protein and mRNA in the brain after systemic LPS injection is affected by age and estrogen , 2006, Journal of Neuroimmunology.

[72]  Meharvan Singh,et al.  Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. , 2006, Endocrinology.

[73]  P. M. Wise,et al.  Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models , 2006, Neuroscience.

[74]  C. Léránth,et al.  Androgen modulation of hippocampal synaptic plasticity , 2006, Neuroscience.

[75]  V. W. Henderson,et al.  Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research , 2006, Neuroscience.

[76]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[77]  R. Matusik,et al.  Comparison of the growth‐promoting effects of testosterone and 7‐α‐methyl‐19‐nor‐testosterone (MENT) on the prostate and levator ani muscle of LPB‐tag transgenic mice , 2006, The Prostate.

[78]  Manuel Estrada,et al.  Ca2+ oscillations induced by testosterone enhance neurite outgrowth , 2006, Journal of Cell Science.

[79]  C. Cotman,et al.  Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. , 2006, Archives of neurology.

[80]  Leon Flicker,et al.  A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life , 2006, Neurobiology of Aging.

[81]  Yadong Huang.  Apolipoprotein E and Alzheimer disease , 2006, Neurology.

[82]  C. Pike,et al.  Conventional protein kinase C isoforms mediate neuroprotection induced by phorbol ester and estrogen , 2006, Journal of neurochemistry.

[83]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[84]  J. Daniel,et al.  Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. , 2006, Endocrinology.

[85]  C. Behl,et al.  Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes , 2005, Neuroscience.

[86]  R. Brinton,et al.  17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection , 2005, Neuroscience.

[87]  Rena Li,et al.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Duane D. Miller,et al.  Structural Basis for Accommodation of Nonsteroidal Ligands in the Androgen Receptor* , 2005, Journal of Biological Chemistry.

[89]  Duane D. Miller,et al.  Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. , 2005, Endocrinology.

[90]  J. Kaufman,et al.  The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.

[91]  Duane D. Miller,et al.  The Para Substituent of S-3-(Phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides Is a Major Structural Determinant of in Vivo Disposition and Activity of Selective Androgen Receptor Modulators , 2005, Journal of Pharmacology and Experimental Therapeutics.

[92]  M. Yao,et al.  Androgens activate mitogen‐activated protein kinase signaling: Role in neuroprotection , 2005, Journal of neurochemistry.

[93]  S. Asthana,et al.  Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment , 2005, Neurology.

[94]  M. Thakur,et al.  Estradiol regulates APP mRNA alternative splicing in the mice brain cortex , 2005, Neuroscience Letters.

[95]  David A Bennett,et al.  Sex differences in the clinical manifestations of Alzheimer disease pathology. , 2005, Archives of general psychiatry.

[96]  S. Paul,et al.  Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. , 2005, Endocrinology.

[97]  J. Ávila,et al.  Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.

[98]  C. Frye,et al.  Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5α-reduced metabolites in the hippocampus , 2005, Psychoneuroendocrinology.

[99]  Sterling C. Johnson,et al.  Clinical Pharmacology and Differential Cognitive Efficacy of Estrogen Preparations , 2005, Annals of the New York Academy of Sciences.

[100]  Meharvan Singh,et al.  Protein Kinase C Activity is Necessary for Estrogen-Induced Erk Phosphorylation in Neocortical Explants , 2005, Neurochemical Research.

[101]  Charles DeCarli,et al.  Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .

[102]  C. Pike,et al.  Neuroprotective properties of selective estrogen receptor agonists in cultured neurons , 2005, Brain Research.

[103]  V. Henderson,et al.  Estrogen and cognition, with a focus on Alzheimer's disease. , 2005, Seminars in reproductive medicine.

[104]  Matthew T. Haren,et al.  Andropause: Is the Emperor Wearing Any Clothes? , 2005, Reviews in Endocrine and Metabolic Disorders.

[105]  Kathryn J. Jones,et al.  Gonadal Steroid Attenuation of Developing Hamster Facial Motoneuron Loss by Axotomy: Equal Efficacy of Testosterone, Dihydrotestosterone, and 17-β Estradiol , 2005, The Journal of Neuroscience.

[106]  F. LaFerla,et al.  Alzheimer's disease: Aβ, tau and synaptic dysfunction , 2005 .

[107]  S. Cummings,et al.  Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. , 2005, The American journal of psychiatry.

[108]  S. Boonen,et al.  Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. , 2005, Bone.

[109]  Jun Wang,et al.  The effect of aging on the subcellular distribution of estrogen receptor‐alpha in the cholinergic neurons of transgenic and wild‐type mice , 2005, The European journal of neuroscience.

[110]  A. Peri,et al.  Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. , 2005, The Journal of clinical endocrinology and metabolism.

[111]  D. Murphy,et al.  The Women's Health Initiative Memory Study: findings and implications for treatment , 2005, The Lancet Neurology.

[112]  A. Day,et al.  Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats. , 2005, Journal of neurobiology.

[113]  Matthew T. Haren,et al.  Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. , 2005, Maturitas.

[114]  Thuy-vi Nguyen,et al.  β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w , 2005, The Journal of Neuroscience.

[115]  Mark A. Smith,et al.  Dysregulation of the Hypothalamic-Pituitary-Gonadal Axis with Menopause and Andropause Promotes Neurodegenerative Senescence , 2005, Journal of neuropathology and experimental neurology.

[116]  M. Kawata,et al.  Progestins and estrogens and Alzheimer's disease , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[117]  Ying Huang,et al.  Estrogen stimulates release of secreted amyloid precursor protein from primary rat cortical neurons via protein kinase C pathway , 2005, Acta Pharmacologica Sinica.

[118]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[119]  C. Behl,et al.  Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. , 2005, Neuroscience.

[120]  N. Hooper,et al.  Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease. , 2005, Trends in molecular medicine.

[121]  T. Nabeshima,et al.  Amyloid pathology and protein kinase C (PKC): possible therapeutics effects of PKC activators. , 2005, Journal of pharmacological sciences.

[122]  R. Brinton.  Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. , 2005, Journal of Alzheimer's disease : JAD.

[123]  R. Green,et al.  Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[124]  A. Granholm,et al.  Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain , 2004, Neuroreport.

[125]  F. Sohrabji,et al.  17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. , 2004, Endocrinology.

[126]  C. Frye,et al.  Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. , 2004, Behavioral neuroscience.

[127]  T. Brown.  Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise. , 2004, Endocrinology.

[128]  A. Gore,et al.  Aging-Related Changes in Ovarian Hormones, Their Receptors, and Neuroendocrine Function , 2004, Experimental biology and medicine.

[129]  R. Martins,et al.  The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? , 2004, Pharmacological research.

[130]  K. Leslie,et al.  Immunomodulatory and Transcriptional Effects of Progesterone Through Progesterone A and B Receptors in Hec50co Poorly Differentiated Endometrial Cancer Cells , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[131]  C. Pike,et al.  Age-related testosterone depletion and the development of Alzheimer disease. , 2004, JAMA.

[132]  R. Tanzi,et al.  Clearance of Alzheimer's Aβ PeptideThe Many Roads to Perdition , 2004 .

[133]  R. Tanzi,et al.  Clearance of Alzheimer's Aβ Peptide The Many Roads to Perdition , 2004, Neuron.

[134]  C. Léránth,et al.  Effects of dehydroepiandrosterone and flutamide on hippocampal CA1 spine synapse density in male and female rats: implications for the role of androgens in maintenance of hippocampal structure. , 2004, Endocrinology.

[135]  L. Hersh,et al.  Estrogen regulates neprilysin activity in rat brain , 2004, Neuroscience Letters.

[136]  C. Frye,et al.  Androgens in the hippocampus can alter, and be altered by, ictal activity , 2004, Pharmacology Biochemistry and Behavior.

[137]  S. Davidge,et al.  Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. , 2004, American journal of physiology. Heart and circulatory physiology.

[138]  JoAnn E Manson,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[139]  L. Thal,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[140]  A. LeBlanc,et al.  Estrogen and Androgen Protection of Human Neurons against Intracellular Amyloid β1-42 Toxicity through Heat Shock Protein 70 , 2004, The Journal of Neuroscience.

[141]  Roberta Diaz Brinton,et al.  Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons , 2004, Brain Research.

[142]  H. Braak,et al.  The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.

[143]  H. Tanila,et al.  Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation , 2004, Experimental Neurology.

[144]  Dick F. Swaab,et al.  Changes in estrogen receptor-α and -β in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology , 2004 .

[145]  Yukiko Nakagawa,et al.  Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. , 2004, Metabolism: clinical and experimental.

[146]  M. Sheffield-Moore,et al.  An overview of the endocrinology of skeletal muscle , 2004, Trends in Endocrinology & Metabolism.

[147]  J. Raber.  Androgens, apoE, and Alzheimer's disease. , 2004, Science of aging knowledge environment : SAGE KE.

[148]  Dick F. Swaab,et al.  Colocalization and alteration of estrogen receptor-α and -β in the hippocampus in Alzheimer’s disease , 2004 .

[149]  H. Soininen,et al.  Hippocampus and entorhinal cortex in mild cognitive impairment and early AD , 2004, Neurobiology of Aging.

[150]  Roberta Diaz Brinton,et al.  Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease , 2004, Experimental Neurology.

[151]  S. Resnick,et al.  Free testosterone and risk for Alzheimer disease in older men , 2004, Neurology.

[152]  M. Pistis,et al.  Low androgenization index in elderly women and elderly men with Alzheimer’s disease , 2004, Neurology.

[153]  PM Maki.  Hormone therapy and risk for dementia: where do we go from here? , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[154]  A. Paganini-Hill,et al.  Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen , 2000, Breast Cancer Research and Treatment.

[155]  S. Hila,et al.  Regulation of cytokine-induced neuron death by ovarian hormones: involvement of antiapoptotic protein expression and c-JUN N-terminal kinase-mediated proapoptotic signaling. , 2004, Endocrinology.

[156]  Dick F Swaab,et al.  Colocalization and alteration of estrogen receptor-alpha and -beta in the hippocampus in Alzheimer's disease. , 2004, Human pathology.

[157]  Andon Hestiantoro,et al.  Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology. , 2004, The Journal of clinical endocrinology and metabolism.

[158]  R. Tanzi,et al.  Clearance of Alzheimer's Abeta peptide: the many roads to perdition. , 2004, Neuron.

[159]  C. Pike,et al.  Androgens modulate neuronal vulnerability to kainate lesion , 2003, Neuroscience.

[160]  Heikki Tanila,et al.  Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice , 2003, Neurobiology of Disease.

[161]  Diederick E Grobbee,et al.  Endogenous sex hormones in men aged 40-80 years. , 2003, European journal of endocrinology.

[162]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[163]  L. Chang,et al.  Androgens modulate β‐amyloid levels in male rat brain , 2003 .

[164]  E. Nieschlag,et al.  A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. , 2003, The Journal of clinical endocrinology and metabolism.

[165]  D. Grandy,et al.  Rapid Signaling of Estrogen in Hypothalamic Neurons Involves a Novel G-Protein-Coupled Estrogen Receptor that Activates Protein Kinase C , 2003, The Journal of Neuroscience.

[166]  J. Gustafsson,et al.  Influence of oestrogen receptor α and β on the immune system in aged female mice , 2003 .

[167]  L. Fallowfield,et al.  The effects of hormone therapy on cognition in breast cancer , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[168]  Leon Flicker,et al.  Testosterone and Dementia: Too much Ado About too Little Data , 2003, The journal of the British Menopause Society.

[169]  F. Sohrabji,et al.  Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals , 2003, Neurobiology of Aging.

[170]  R. Brinton,et al.  Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[171]  L. Gooren.  Androgen deficiency in the aging male: benefits and risks of androgen supplementation , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[172]  J. Morley,et al.  Androgen treatment of male hypogonadism in older males , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[173]  A. Smith,et al.  Testosterone and gonadotropin levels in men with dementia. , 2003, Neuro endocrinology letters.

[174]  J. Culberson,et al.  An integrative review on current evidence of testosterone replacement therapy for the andropause. , 2003, Maturitas.

[175]  J. Manson,et al.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[176]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[177]  Wickliffe C Abraham,et al.  Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory , 2003, Progress in Neurobiology.

[178]  E. Dudley,et al.  Estrogen exposures and memory at midlife , 2003, Neurology.

[179]  L. Young,et al.  Uncoupling of 5-HT1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780 , 2003, Neuropharmacology.

[180]  B. Sherwin,et al.  Estrogen and cognitive functioning in women. , 2003, Endocrine reviews.

[181]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[182]  S. Asthana,et al.  17β-Estradiol Reduces Plasma Aβ40 for HRT-Naïve Postmenopausal Women With Alzheimer Disease: A Preliminary Study , 2003 .

[183]  C. Pike,et al.  Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.

[184]  Roberta Diaz Brinton,et al.  Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[185]  R. Tan,et al.  A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease , 2003, The aging male : the official journal of the International Society for the Study of the Aging Male.

[186]  L. Chang,et al.  Androgens modulate beta-amyloid levels in male rat brain. , 2003, Journal of neurochemistry.

[187]  S. Asthana,et al.  17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study. , 2003, The American journal of geriatric psychiatry.

[188]  R. Martins,et al.  Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. , 2003, Journal of Alzheimer's disease : JAD.

[189]  J. Gustafsson,et al.  Influence of oestrogen receptor alpha and beta on the immune system in aged female mice. , 2003, Immunology.

[190]  K. Channer,et al.  Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. , 2003, European journal of endocrinology.

[191]  S. Resnick,et al.  Hormone therapy and risk of Alzheimer disease: a critical time. , 2002, JAMA.

[192]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[193]  Rena Li,et al.  Microglia and inflammatory mechanisms in the clearance of amyloid β peptide , 2002 .

[194]  S. Resnick,et al.  Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. , 2002, The Journal of clinical endocrinology and metabolism.

[195]  A. Smith,et al.  Apolipoprotein E ε4 and testosterone interact in the risk of Alzheimer's disease in men , 2002 .

[196]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[197]  Julie A. Harris,et al.  Estrogen‐mediated neuroprotection against β‐amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway , 2002 .

[198]  R. Brinton,et al.  Impact of progestins on estradiol potentiation of the glutamate calcium response , 2002, Neuroreport.

[199]  Paul Greengard,et al.  Estrogen Lowers Alzheimer β-Amyloid Generation by Stimulatingtrans-Golgi Network Vesicle Biogenesis* , 2002, The Journal of Biological Chemistry.

[200]  Myles Brown,et al.  Molecular Determinants for the Tissue Specificity of SERMs , 2002, Science.

[201]  E. Wilson,et al.  The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators* , 2002, The Journal of Biological Chemistry.

[202]  Roberta Diaz Brinton,et al.  Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway , 2002, Brain Research.

[203]  R. Wolfe,et al.  Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. , 2002, American journal of physiology. Endocrinology and metabolism.

[204]  E. Vittinghoff,et al.  Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. , 2002, JAMA.

[205]  T. Olsson,et al.  Increased Levels of Adrenocortical and Gonadal Hormones in Mild to Moderate Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[206]  A. Araujo,et al.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. , 2002, The Journal of clinical endocrinology and metabolism.

[207]  K. Leslie,et al.  Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. , 2002, Cancer research.

[208]  S. Papasozomenos,et al.  Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3β but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of τ: Implications for Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[209]  J. Lafrancois,et al.  Modulation of Aβ peptides by estrogen in mouse models , 2002, Journal of neurochemistry.

[210]  Jonathan D. Smith,et al.  17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. , 2002, Journal of Alzheimer's disease : JAD.

[211]  Jonathan D. Smith,et al.  17α-estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice , 2002 .

[212]  Julie A. Harris,et al.  Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. , 2002, Journal of neurochemistry.

[213]  A. Smith,et al.  Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. , 2002, International journal of geriatric psychiatry.

[214]  M. Rowan,et al.  Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. , 2002, Biochemical Society transactions.

[215]  J. Simpkins,et al.  Modulation of A(beta) peptides by estrogen in mouse models. , 2002, Journal of neurochemistry.

[216]  Rena Li,et al.  Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. , 2002, Glia.

[217]  A. Day,et al.  Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. , 2002, Journal of applied physiology.

[218]  P. Zandi,et al.  Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study , 2001 .

[219]  C. Frye,et al.  Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats , 2001, Cognitive, affective & behavioral neuroscience.

[220]  R. Casaburi,et al.  Testosterone dose-response relationships in healthy young men. , 2001, American journal of physiology. Endocrinology and metabolism.

[221]  C. Pike.  Testosterone attenuates β-amyloid toxicity in cultured hippocampal neurons , 2001, Brain Research.

[222]  C. Woolley,et al.  Quantitative analysis of ERα and GAD colocalization in the hippocampus of the adult female rat , 2001 .

[223]  Kathryn J. Jones,et al.  Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons , 2001, Brain Research Reviews.

[224]  B. Teter,et al.  Estrogen (E2) and glucocorticoid (Gc) effects on microglia and Aβ clearance in vitro and in vivo , 2001, Neurochemistry International.

[225]  C. Cotman,et al.  Estrogen regulates bcl-x expression in rat hippocampus , 2001, Neuroreport.

[226]  Y. Suh,et al.  Estrogen attenuates cell death induced by carboxy‐terminal fragment of amyloid precursor protein in PC12 through a receptor‐dependent pathway , 2001, Journal of neuroscience research.

[227]  S. Heck,et al.  Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. , 2001, European journal of biochemistry.

[228]  Michael J. Rowan,et al.  Amyloid-β oligomers: their production, toxicity and therapeutic inhibition , 2001 .

[229]  R. Ravid,et al.  Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer’s disease , 2001, Brain Research.

[230]  S. Asthana,et al.  Testosterone supplementation improves spatial and verbal memory in healthy older men , 2001, Neurology.

[231]  D. Rubinow,et al.  Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. , 2001, Neuroreport.

[232]  A. Maggi,et al.  Engineering of a mouse for the in vivo profiling of estrogen receptor activity. , 2001, Molecular endocrinology.

[233]  Monique M. B. Breteler,et al.  Incidence of dementia: does gender make a difference? , 2001, Neurobiology of Aging.

[234]  N. Harada,et al.  Brain aromatase is neuroprotective. , 2001, Journal of neurobiology.

[235]  A. Smith,et al.  Serum total testosterone is lower in men with Alzheimer's disease. , 2001, Neuro endocrinology letters.

[236]  A. LeBlanc,et al.  Testosterone‐mediated neuroprotection through the androgen receptor in human primary neurons , 2001, Journal of neurochemistry.

[237]  R. Martins,et al.  Chemical andropause and amyloid-beta peptide. , 2001, JAMA.

[238]  D. B. Williams,et al.  Effects of hormone replacement therapy on cognitive performance in elderly women. , 2001, Maturitas.

[239]  K Yaffe,et al.  Cognitive function in postmenopausal women treated with raloxifene. , 2001, The New England journal of medicine.

[240]  I. Mook‐Jung,et al.  Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells , 2001, Neuroscience Letters.

[241]  J. Janowsky,et al.  Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.

[242]  A. Sala,et al.  Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia , 2001, The Journal of Neuroscience.

[243]  F. Bian,et al.  Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.

[244]  F. Sohrabji,et al.  Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation , 2001, Neurobiology of Aging.

[245]  J. Morley,et al.  Androgens and aging. , 2001, Maturitas.

[246]  G. Prins,et al.  Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism , 2001, Brain Research.

[247]  S. Gandy,et al.  Regulation of alzheimer beta-amyloid precursor trafficking and metabolism. , 2000, Advances in experimental medicine and biology.

[248]  J. Rhodin,et al.  Estrogen and Raloxifene Activities on Amyloid-β-Induced Inflammatory Reaction , 2001 .

[249]  C. Pike.  Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. , 2001, Brain research.

[250]  R. Ravid,et al.  Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease. , 2001, Brain research.

[251]  C. Woolley,et al.  Quantitative analysis of ER alpha and GAD colocalization in the hippocampus of the adult female rat. , 2001, The Journal of comparative neurology.

[252]  P. Wise,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Neuroprotective Effects of Estradiol in Middle-Aged Female Rats* , 2000 .

[253]  L. Hersh,et al.  Identification and characterization of two androgen response regions in the human neutral endopeptidase gene , 2000, Molecular and Cellular Endocrinology.

[254]  C. Behl,et al.  Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway , 2000, Neuroscience Letters.

[255]  R. Gibbs.  Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function , 2000, Neuroscience.

[256]  M. Mattson,et al.  Antiinflammatory effects of estrogen on microglial activation. , 2000, Endocrinology.

[257]  C. Finch,et al.  Estrogen Enhances Uptake of Amyloid β‐Protein by Microglia Derived from the Human Cortex , 2000, Journal of neurochemistry.

[258]  L. Mello,et al.  Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats , 2000, Neuroscience Letters.

[259]  B. Breuer,et al.  The Relationship of Tamoxifen with Dementia, Depression, and Dependence in Activities of Daily Living in Elderly Nursing Home Residents , 2000, Women & health.

[260]  T. Morgan,et al.  Effects of Age on Gene Expression during Estrogen-Induced Synaptic Sprouting in the Female Rat , 2000, Experimental Neurology.

[261]  P. Davies,et al.  Conformational change as one of the earliest alterations of tau in Alzheimer’s disease , 2000, Neurobiology of Aging.

[262]  T. Saido,et al.  Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?' , 2000, Nature Medicine.

[263]  S. Gandy,et al.  Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain , 2000, Neurology.

[264]  H C Liu,et al.  Effects of estrogen on cognition, mood, and cerebral blood flow in AD , 2000, Neurology.

[265]  K. Breen,et al.  Factors influencing the processing and function of the amyloid beta precursor protein--a potential therapeutic target in Alzheimer's disease? , 2000, Pharmacology & therapeutics.

[266]  C. Wade,et al.  The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection , 2000, Journal of neurocytology.

[267]  J. Janowsky,et al.  Sex Steroids Modify Working Memory , 2000, Journal of Cognitive Neuroscience.

[268]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[269]  B. Vincent,et al.  Effect of estradiol on neuronal Swedish-mutated beta-amyloid precursor protein metabolism: reversal by astrocytic cells. , 2000, Biochemical and biophysical research communications.

[270]  G. Palumbo,et al.  17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence , 2000, Molecular and Cellular Biology.

[271]  R. Brinton,et al.  The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. , 2000, Maturitas.

[272]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[273]  R. Mayeux,et al.  Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women , 2000, Neurology.

[274]  P. Greengard,et al.  Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[275]  T. Saido,et al.  Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.

[276]  I. Merchenthaler,et al.  Estrogen is More Than just a “Sex Hormone”: Novel Sites for Estrogen Action in the Hippocampus and Cerebral Cortex , 2000, Frontiers in Neuroendocrinology.

[277]  B L Miller,et al.  Estrogen for Alzheimer’s disease in women , 2000, Neurology.

[278]  R. Gibbs.  Oestrogen and the cholinergic hypothesis: implications for oestrogen replacement therapy in postmenopausal women. , 2000, Novartis Foundation symposium.

[279]  S. Gandy,et al.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. , 2000, Experimental gerontology.

[280]  R. Traystman,et al.  Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. , 2000, Stroke.

[281]  C. Pike,et al.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.

[282]  L. Garcia-Segura,et al.  Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin‐like growth factor‐I signalling , 1999, Journal of neuroscience research.

[283]  A Hofman,et al.  Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.

[284]  S. Paul,et al.  Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats , 1999, Brain Research.

[285]  John Calvin Reed,et al.  Mechanisms of Transcriptional Activation of bcl-2Gene Expression by 17β-Estradiol in Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[286]  H. Braak,et al.  Sex-Dependent Cytoskeletal Changes of the Human Hypothalamus Develop Independently of Alzheimer's Disease , 1999, Experimental Neurology.

[287]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[288]  D. Baird,et al.  7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. , 1999, The Journal of clinical endocrinology and metabolism.

[289]  E. Barrett-Connor,et al.  Endogenous sex hormones and cognitive function in older men. , 1999, The Journal of clinical endocrinology and metabolism.

[290]  L. Tanzer,et al.  Androgenic regulation of the central glia response following nerve damage. , 1999, Journal of neurobiology.

[291]  D. Lindholm,et al.  Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[292]  P. Shughrue,et al.  Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors , 1999, The Journal of Neuroscience.

[293]  D. Geschwind,et al.  Tau Mutations in Frontotemporal Dementia , 1999, Dementia and Geriatric Cognitive Disorders.

[294]  C. Behl,et al.  Estrogen Hormones Reduce Lipid Peroxidation in Cells and Tissues of the Central Nervous System , 1999, Journal of neurochemistry.

[295]  Meharvan Singh,et al.  Novel Mechanisms of Estrogen Action in the Brain: New Players in an Old Story , 1999, Frontiers in Neuroendocrinology.

[296]  F. Figueras,et al.  Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[297]  D. Dorsa,et al.  The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.

[298]  R. Baumgartner,et al.  Predictors of skeletal muscle mass in elderly men and women , 1999, Mechanisms of Ageing and Development.

[299]  L. Garcia-Segura,et al.  Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair , 1999, Neuroscience.

[300]  E G Tangalos,et al.  Postmenopausal estrogen replacement therapy and risk of AD , 1999, Neurology.

[301]  Xiaoping Guan,et al.  Estrogen-Induced Activation of Mitogen-Activated Protein Kinase in Cerebral Cortical Explants: Convergence of Estrogen and Neurotrophin Signaling Pathways , 1999, The Journal of Neuroscience.

[302]  J. Jolles,et al.  The effect of hormone replacement therapy on cognitive function in elderly women , 1999, Psychoneuroendocrinology.

[303]  S. Papasozomenos,et al.  Androgens Prevent the Heat Shock-Induced Hyperphosphorylation but not Dephosphorylation of t in Female Rats. Implications for Alzheimer's Disease. , 1999, Journal of Alzheimer's disease : JAD.

[304]  A. Strasser,et al.  The Bcl-2 protein family. , 1999, Results and problems in cell differentiation.

[305]  D. Cummings,et al.  Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception. , 1998, The Journal of clinical endocrinology and metabolism.

[306]  J. Simpkins,et al.  Estrogen attenuates over-expression of β-amyloid precursor protein messager RNA in an animal model of focal ischemia , 1998, Brain Research.

[307]  Carl W. Cotman,et al.  β-Amyloid Induces Local Neurite Degeneration in Cultured Hippocampal Neurons: Evidence for Neuritic Apoptosis , 1998, Neurobiology of Disease.

[308]  M. Mattson,et al.  Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.

[309]  L. Garcia-Segura,et al.  Estradiol prevents kainic acid‐induced neuronal loss in the rat dentate gyrus , 1998, Neuroreport.

[310]  D. Dorsa,et al.  Modulation of Bcl‐2 expression: a potential component of estrogen protection in NT2 neurons , 1998, Neuroreport.

[311]  A. M. Etgen,et al.  Estradiol Elevates Protein Kinase C Catalytic Activity in the Preoptic Area of Female Rats* Materials and Methods Tissue Slice Preparation , 2022 .

[312]  G. Mor,et al.  Raloxifene Induces Neurite Outgrowth in, Estrogen Receptor Positive PC 12 Cells , 1998, Menopause.

[313]  C. Frye,et al.  ANDROGENIC NEUROSTEROIDS: ANTI-SEIZURE EFFECTS IN AN ANIMAL MODEL OF EPILEPSY , 1998, Psychoneuroendocrinology.

[314]  A Hofman,et al.  Risk factors for increased bone loss in an elderly population: the Rotterdam Study. , 1998, American journal of epidemiology.

[315]  L. Garcia-Segura,et al.  Estradiol upregulates Bcl‐2 expression in adult brain neurons , 1998, Neuroreport.

[316]  H Helenius,et al.  The Effect of Short‐Term Estrogen Replacement Therapy on Cognition: A Randomized, Double‐Blind, Cross‐Over Trial in Postmenopausal Women , 1998, Obstetrics and gynecology.

[317]  K. Fischbeck,et al.  A Cell Culture Model for Androgen Effects in Motor Neurons , 1998, Journal of neurochemistry.

[318]  H. Bryant,et al.  Selective Estrogen Receptor Modulators: An Alternative to Hormone Replacement Therapy , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[319]  M. Mattson,et al.  Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.

[320]  P. Greengard,et al.  Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. , 1998, Nature medicine.

[321]  J. Simpkins,et al.  Low concentrations of estradiol reduce β-amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells , 1997, Brain Research.

[322]  C. Christiansen,et al.  Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. , 1997, The New England journal of medicine.

[323]  R. Brookmeyer,et al.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer''s disease , 1997 .

[324]  R. Horwitz,et al.  The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. , 1997, Journal of clinical epidemiology.

[325]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[326]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[327]  I. Mook‐Jung,et al.  Estrogen blocks neurotoxic effects of β-amyloid (1–42) and induces neurite extension on B103 cells , 1997, Neuroscience Letters.

[328]  E. Krebs,et al.  Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. , 1997, Endocrinology.

[329]  Raymond F Regan,et al.  Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures , 1997, Brain Research.

[330]  J. Graham,et al.  Physiological action of progesterone in target tissues. , 1997, Endocrine reviews.

[331]  D. Farb,et al.  17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors , 1997, Brain Research.

[332]  Kathryn J Jones,et al.  Gonadal Steroid Regulation of Hamster Facial Nerve Regeneration: Effects of Dihydrotestosterone and Estradiol , 1997, Experimental Neurology.

[333]  S. Papasozomenos,et al.  The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[334]  F. Holsboer,et al.  Protection Against Oxidative Stress‐induced Neuronal Cell Death‐A Novel Role for RU486 , 1997, The European journal of neuroscience.

[335]  C. Rice-Evans,et al.  Antioxidant properties of phenolic compounds , 1997 .

[336]  P J Garry,et al.  Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. , 1997, Metabolism: clinical and experimental.

[337]  G. Alexander,et al.  Androgen–Behavior Correlations in Hypogonadal Men and Eugonadal Men , 1997, Hormones and Behavior.

[338]  J. Hardy,et al.  The Alzheimer family of diseases: many etiologies, one pathogenesis? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[339]  Kooma Eh.  Phorbol esters affect multiple steps in beta-amyloid precursor protein trafficking and amyloid beta-protein production. , 1997 .

[340]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[341]  E. Koo.  Phorbol esters affect multiple steps in beta-amyloid precursor protein trafficking and amyloid beta-protein production. , 1997, Molecular medicine.

[342]  P. Timiras,et al.  Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line. , 1997, Advances in experimental medicine and biology.

[343]  J. Simpkins,et al.  Estradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells , 1996, Neuroscience Letters.

[344]  V. Henderson,et al.  Estrogen replacement therapy and risk of Alzheimer disease. , 1996, Archives of internal medicine.

[345]  J. Loike,et al.  Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.

[346]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[347]  H. Braak,et al.  A sex difference in neurodegeneration of the human hypothalamus , 1996, Neuroscience Letters.

[348]  D. Dorsa,et al.  Estrogen protects primary cortical neurons from glutamate toxicity , 1996, Neuroscience Letters.

[349]  B. Hyman,et al.  Apolipoprotein E and cognitive change in an elderly population , 1996, Annals of neurology.

[350]  P. S. St George-Hyslop,et al.  Alzheimer's disease , 1996, Neurology.

[351]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.

[352]  D. Dluzen.  Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice , 1996, Brain Research.

[353]  D. Selkoe,et al.  The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Protein a , 1996 .

[354]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[355]  J. Loike,et al.  Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. , 1996, Nature.

[356]  D. Selkoe,et al.  The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. , 1996, Annals of the New York Academy of Sciences.

[357]  F. Holsboer,et al.  17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. , 1995, Biochemical and biophysical research communications.

[358]  M. Mattson,et al.  Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons , 1995, Journal of neurochemistry.

[359]  M. Mattson,et al.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[360]  C. Brayne,et al.  Incidence of Clinically Diagnosed Subtypes of Dementia in an Elderly Population , 1995, British Journal of Psychiatry.

[361]  J. Goebel,et al.  Estrogen replacement therapy and postural stability in the elderly. , 1995, The American journal of otology.

[362]  K. Kujawa,et al.  Inhibition of the Accelerative Effects of Testosterone on Hamster Facial Nerve Regeneration by the Antiandrogen Flutamide , 1995, Experimental Neurology.

[363]  L. Garcia-Segura,et al.  Neuroactive steroids regulate astroglia morphology in hippocampal cultures from adult rats , 1995, Glia.

[364]  K. Kerlikowske,et al.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis. , 1995, Obstetrics and gynecology.

[365]  Susan R. Johnson,et al.  Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .

[366]  Brian J Cummings,et al.  β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease , 1994, Neuroscience.

[367]  J. Buckwalter,et al.  Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. , 1994, Archives of neurology.

[368]  N. Hagino,et al.  Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. , 1994, Endocrine journal.

[369]  V. Henderson,et al.  Estrogen deficiency and risk of Alzheimer's disease in women. , 1994, American journal of epidemiology.

[370]  E B Larson,et al.  Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. , 1994, American journal of epidemiology.

[371]  M. Mattson,et al.  Secreted Forms of β-Amyloid Precursor Protein Protect Hippocampal Neurons against Amyloid β-Peptide-Induced Oxidative Injury , 1994, Experimental Neurology.

[372]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[373]  P. Greengard,et al.  Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. , 1994, The Journal of biological chemistry.

[374]  C. Cotman,et al.  Rapid Communication: Ca2+ Channel Blockers Attenuate β‐Amyloid Peptide Toxicity to Cortical Neurons in Culture , 1994 .

[375]  J. Buckwalter,et al.  Cognitive deficits of men and women with Alzheimer's disease , 1994, Neurology.

[376]  C. Cotman,et al.  Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. , 1994, Journal of neurochemistry.

[377]  J. Janowsky,et al.  Testosterone influences spatial cognition in older men. , 1994, Behavioral neuroscience.

[378]  Brian J Cummings,et al.  Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. , 1994, Neuroscience.

[379]  Z. Rymaszewski,et al.  Antioxidant potential of specific estrogens on lipid peroxidation. , 1994, The Journal of clinical endocrinology and metabolism.

[380]  E. Soriano,et al.  Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury , 1993, Brain Research.

[381]  R. Swerdloff,et al.  Androgen deficiency and aging in men. , 1993, The Western journal of medicine.

[382]  C. Woolley,et al.  Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat , 1993, The Journal of comparative neurology.

[383]  A. E. Lemus,et al.  Induction of male sexual behavior in the rat by 7 alpha-methyl-19-nortestosterone, an androgen that does not undergo 5 alpha-reduction. , 1993, Biology of reproduction.

[384]  E Sobel,et al.  Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. , 1993, Archives of neurology.

[385]  K. Kujawa,et al.  Testosterone regulation of the regenerative properties of injured rat sciatic motor neurons , 1993, Journal of neuroscience research.

[386]  E. Barrett-Connor,et al.  Estrogen replacement therapy and cognitive function in older women. , 1993, JAMA.

[387]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[388]  Brian J Cummings,et al.  beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. , 1992, Neuroreport.

[389]  C. Cotman,et al.  β-Amyloid neurotoxicity: A discussion of in vitro findings , 1992, Neurobiology of Aging.

[390]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[391]  R. D'Agostino,et al.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study , 1992, Neurology.

[392]  O. Hagnell,et al.  Incidence of dementia in the Lundby Study. , 1992, Neuroepidemiology.

[393]  D. Kimura,et al.  The relationship between testosterone levels and cognitive ability patterns , 1991, Psychoneuroendocrinology.

[394]  K. Jones,et al.  Testosterone differentially regulates the regenerative properties of injured hamster facial motoneurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[395]  J. Mckinlay,et al.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. , 1991, The Journal of clinical endocrinology and metabolism.

[396]  C. Cotman,et al.  Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. , 1991, European journal of pharmacology.

[397]  C. Cotman,et al.  β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.

[398]  H. Braak,et al.  Alzheimer's Disease: Striatal Amyloid Deposits and Neurofibrillary Changes , 1990, Journal of neuropathology and experimental neurology.

[399]  L. Swanson,et al.  Distribution of androgen and estrogen receptor mRNA‐containing cells in the rat brain: An in situ hybridization study , 1990, The Journal of comparative neurology.

[400]  J. Liehr,et al.  Free radical generation by redox cycling of estrogens. , 1990, Free radical biology & medicine.

[401]  C. Woolley,et al.  Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: a Golgi study in the adult rat. , 1990, Neuroendocrinology.

[402]  V. Perry,et al.  Microglia in the neurohypophysis associate with and endocytose terminal portions of neurosecretory neurons , 1989, Neuroscience.

[403]  Wh Yu.  Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[404]  K. Kujawa,et al.  Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters , 1989, Experimental Neurology.

[405]  R. Hoover,et al.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. , 1989, BMJ.

[406]  B. Sherwin,et al.  Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women , 1988, Psychoneuroendocrinology.

[407]  Anthony F. Jorm,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[408]  D. Meier,et al.  Marked Decline in Trabecular Bone Mineral Content in Healthy Men with Age: Lack of Association with Sex Steroid Levels , 1987, Journal of the American Geriatrics Society.

[409]  D. Choi.  Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[410]  M. Nakano,et al.  Estrogens as natural antioxidants of membrane phospholipid peroxidation , 1987, FEBS letters.

[411]  B. Rubin,et al.  Estrogen binding in nuclear and cytosolic extracts from brain and pituitary of middle-aged female rats , 1986, Brain Research.

[412]  W. Rocca,et al.  Epidemiology of clinically diagnosed Alzheimer's disease , 1986, Annals of neurology.

[413]  C. Finch,et al.  Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. , 1984, Biology of reproduction.

[414]  B. Parsons,et al.  Nuclear estradiol and cytosol progestin receptor concentrations in the brain and the pituitary gland and sexual behavior in ovariectomized estradiol-treated middle-aged rats. , 1984, Endocrinology.

[415]  C. Finch,et al.  Aging and the regulation of luteinizing hormone in C57BL/6J mice: impaired elevations after ovariectomy and spontaneous elevations at advanced ages. , 1983, Biology of reproduction.

[416]  C. Finch,et al.  Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6J mice. , 1983, Biology of reproduction.

[417]  W. Yu.  Effect of testosterone on the regeneration of the hypoglossal nerve in rats , 1982, Experimental Neurology.

[418]  P. Mölsä,et al.  Epidemiology of dementia in a Finnish population , 1982, Acta neurologica Scandinavica.

[419]  W. A. Yu,et al.  Effect of testosterone and 5α-dihydrotestosterone on regeneration of the hypoglossal nerve in rats , 1981, Experimental Neurology.

[420]  F. Ebling.  Androgens , 1964 .